BioCentury
ARTICLE | Company News

Management tracks: Alder, BIO

June 7, 2018 11:06 PM UTC

Neurology company Alder BioPharmaceuticals Inc. (NASDAQ:ALDR) hired Robert Azelby as president and CEO, effective June 13. Azelby was EVP and chief commercial officer at Juno Therapeutics Inc., which Celgene Corp. (NASDAQ:CELG) acquired.

The Biotechnology Innovation Organization elected Katrine Bosley as chair of the emerging companies section governing board and Jeremy Levin as vice chair of the health section governing board. Bosely is CEO of Editas Medicine Inc. (NASDAQ:EDIT) and Levin is chairman and CEO of Ovid Therapeutics Inc. (NASDAQ:OVID)...